Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 5th edition, 486 pages

Free download


  COVID-19

  Free Subscription


Articles published in J Virol

Retrieve available abstracts of 57 articles:
HTML format



Single Articles


    November 2020
  1. YUAN LX, Liang JQ, Zhu QC, Dai G, et al
    Gammacoronavirus Avian Infectious Bronchitis Virus and Alphacoronavirus Porcine Epidemic Diarrhea Virus Exploit a Cell-Survival Strategy via Upregulation of cFOS to Promote Viral Replication.
    J Virol. 2020 Nov 25. pii: JVI.02107-20. doi: 10.1128/JVI.02107.
    PubMed     Abstract available


  2. WESTERGREN JAKOBSSON A, Segerman B, Wallerman O, Lind SB, et al
    The Human Adenovirus Type 2 Transcriptome: An Amazing Complexity of Alternatively Spliced mRNAs.
    J Virol. 2020 Nov 25. pii: JVI.01869-20. doi: 10.1128/JVI.01869.
    PubMed     Abstract available


  3. CLARK LK, Green TJ, Petit CM
    Structure of nonstructural protein 1 from SARS-CoV-2.
    J Virol. 2020 Nov 24. pii: JVI.02019-20. doi: 10.1128/JVI.02019.
    PubMed     Abstract available


  4. MILEWSKA A, Chi Y, Szczepanski A, Barreto-Duran E, et al
    HTCC as a Polymeric Inhibitor of SARS-CoV-2 and MERS-CoV.
    J Virol. 2020 Nov 20. pii: JVI.01622-20. doi: 10.1128/JVI.01622.
    PubMed     Abstract available


  5. UJIKE M, Kawachi Y, Matsunaga Y, Etho Y, et al
    Characterization of localization and export signals of bovine torovirus nucleocapsid protein responsible for extensive nuclear and nucleolar accumulation and their importance for virus growth.
    J Virol. 2020 Nov 11. pii: JVI.02111-20. doi: 10.1128/JVI.02111.
    PubMed     Abstract available


  6. TANDON R, Sharp JS, Zhang F, Pomin VH, et al
    Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives.
    J Virol. 2020 Nov 10. pii: JVI.01987-20. doi: 10.1128/JVI.01987.
    PubMed     Abstract available


  7. ALHAMMAD YMO, Kashipathy MM, Roy A, Gagne JP, et al
    The SARS-CoV-2 conserved macrodomain is a mono-ADP-ribosylhydrolase.
    J Virol. 2020 Nov 6. pii: JVI.01969-20. doi: 10.1128/JVI.01969.
    PubMed     Abstract available


  8. FENWICK C, Croxatto A, Coste AT, Pojer F, et al
    Changes in SARS-CoV-2 Spike versus Nucleoprotein Antibody Responses Impact the Estimates of Infections in Population-Based Seroprevalence Studies.
    J Virol. 2020 Nov 3. pii: JVI.01828-20. doi: 10.1128/JVI.01828.
    PubMed     Abstract available


  9. HEISE M, Dermody TS, Casadevall A, Sandri-Goldin RM, et al
    The Decision to Publish Gutierrez-Alvarez et al., "Middle East Respiratory Syndrome Coronavirus Gene 5 Modulates Pathogenesis in Mice".
    J Virol. 2020 Nov 3. pii: JVI.02118-20. doi: 10.1128/JVI.02118.
    PubMed     Abstract available


  10. GUTIERREZ-ALVAREZ J, Wang L, Fernandez-Delgado R, Li K, et al
    Middle East Respiratory Syndrome Coronavirus Gene 5 Modulates Pathogenesis in Mice.
    J Virol. 2020 Nov 3. pii: JVI.01172-20. doi: 10.1128/JVI.01172.
    PubMed     Abstract available


    October 2020
  11. DIEZ-FUERTES F, Iglesias-Caballero M, Garcia Perez J, Monzon S, et al
    A FOUNDER EFFECT LED EARLY SARS-COV-2 TRANSMISSION IN SPAIN.
    J Virol. 2020 Oct 30. pii: JVI.01583-20. doi: 10.1128/JVI.01583.
    PubMed     Abstract available


  12. MATSUYAMA S, Kawase M, Nao N, Shirato K, et al
    The inhaled steroid ciclesonide blocks SARS-CoV-2 RNA replication by targeting the viral replication-transcription complex in cultured cells.
    J Virol. 2020 Oct 14. pii: JVI.01648-20. doi: 10.1128/JVI.01648.
    PubMed     Abstract available


    September 2020
  13. SYAGE AR, Ekiz HA, Skinner DD, Stone C, et al
    Single-cell RNA sequencing reveals the diversity of the immunological landscape following CNS infection by a murine coronavirus.
    J Virol. 2020 Sep 30. pii: JVI.01295-20. doi: 10.1128/JVI.01295.
    PubMed     Abstract available


  14. HU Y, Li W, Gao T, Cui Y, et al
    Correction for Hu et al., "The Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Inhibits Type I Interferon Production by Interfering with TRIM25-Mediated RIG-I Ubiquitination".
    J Virol. 2020;94.
    PubMed    


  15. CHOI JA, Goo J, Yang E, Jung DI, et al
    Cross-Protection against MERS-CoV by Prime-Boost Vaccination Using Viral Spike DNA and Protein.
    J Virol. 2020 Sep 23. pii: JVI.01176-20. doi: 10.1128/JVI.01176.
    PubMed     Abstract available


  16. OGANDO NS, Zevenhoven-Dobbe JC, van der Meer Y, Bredenbeek PJ, et al
    The enzymatic activity of the nsp14 exoribonuclease is critical for replication of MERS-CoV and SARS-CoV-2.
    J Virol. 2020 Sep 16. pii: JVI.01246-20. doi: 10.1128/JVI.01246.
    PubMed     Abstract available


  17. LOKUGAMAGE KG, Hage A, de Vries M, Valero-Jimenez AM, et al
    Type I interferon susceptibility distinguishes SARS-CoV-2 from SARS-CoV.
    J Virol. 2020 Sep 16. pii: JVI.01410-20. doi: 10.1128/JVI.01410.
    PubMed     Abstract available


  18. CHANDRASEKAR SS, Kingstad-Bakke B, Wu CW, Suresh M, et al
    A Novel Mucosal Adjuvant System for Immunization against Avian Coronavirus Causing Infectious Bronchitis.
    J Virol. 2020;94.
    PubMed     Abstract available


  19. BROCATO RL, Principe LM, Kim RK, Zeng X, et al
    Disruption of Adaptive Immunity Enhances Disease in SARS-CoV-2 Infected Syrian Hamsters.
    J Virol. 2020 Sep 8. pii: JVI.01683-20. doi: 10.1128/JVI.01683.
    PubMed     Abstract available


    August 2020
  20. LI Y, Wang H, Tang X, Fang S, et al
    SARS-CoV-2 and three related coronaviruses utilize multiple ACE2 orthologs and are potently blocked by an improved ACE2-Ig.
    J Virol. 2020 Aug 26. pii: JVI.01283-20. doi: 10.1128/JVI.01283.
    PubMed     Abstract available


  21. FROGGATT HM, Heaton BE, Heaton NS
    Development of a fluorescence based, high-throughput SARS-CoV-2 3CL(pro) reporter assay.
    J Virol. 2020 Aug 25. pii: JVI.01265-20. doi: 10.1128/JVI.01265.
    PubMed     Abstract available


  22. GUAN H, Wang Y, Perculija V, Saeed AFUH, et al
    Cryo-electron microscopy structure of the SADS-CoV spike glycoprotein provides insights into an evolution of unique coronavirus spike proteins.
    J Virol. 2020 Aug 19. pii: JVI.01301-20. doi: 10.1128/JVI.01301.
    PubMed     Abstract available


  23. WESTON S, Coleman CM, Haupt R, Logue J, et al
    Broad anti-coronaviral activity of FDA approved drugs against SARS-CoV-2 in vitro and SARS-CoV in vivo.
    J Virol. 2020 Aug 19. pii: JVI.01218-20. doi: 10.1128/JVI.01218.
    PubMed     Abstract available


  24. SI F, Chen B, Hu X, Yu R, et al
    Porcine Epidemic Diarrhea Virus ORF3 Protein Is Transported through the Exocytic Pathway.
    J Virol. 2020;94.
    PubMed     Abstract available


  25. HWANG M, Bergmann CC
    Neuronal ablation of IFNalpha/beta signaling exacerbates CNS viral dissemination and impairs IFNgamma responsiveness in microglia/macrophages.
    J Virol. 2020 Aug 12. pii: JVI.00422-20. doi: 10.1128/JVI.00422.
    PubMed     Abstract available


  26. JOHNSON MC, Lyddon TD, Suarez R, Salcedo B, et al
    Optimized pseudotyping conditions for the SARS COV-2 Spike glycoprotein.
    J Virol. 2020 Aug 11. pii: JVI.01062-20. doi: 10.1128/JVI.01062.
    PubMed     Abstract available


    July 2020
  27. GUO H, Hu BJ, Yang XL, Zeng LP, et al
    Evolutionary arms race between virus and host drives genetic diversity in bat SARS related coronavirus spike genes.
    J Virol. 2020 Jul 22. pii: JVI.00902-20. doi: 10.1128/JVI.00902.
    PubMed     Abstract available


  28. VANDERHEIDEN A, Ralfs P, Chirkova T, Upadhyay AA, et al
    Type I and Type III IFN Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures.
    J Virol. 2020 Jul 22. pii: JVI.00985-20. doi: 10.1128/JVI.00985.
    PubMed     Abstract available


  29. WANG Y, Sun J, Li X, Zhu A, et al
    Increased Pathogenicity and Virulence of Middle East Respiratory Syndrome Coronavirus Clade B In Vitro and In Vivo.
    J Virol. 2020;94.
    PubMed     Abstract available


  30. AHLEN G, Frelin L, Nekoyan N, Weber F, et al
    The SARS-CoV-2 N protein is a good component in a vaccine.
    J Virol. 2020 Jul 13. pii: JVI.01279-20. doi: 10.1128/JVI.01279.
    PubMed     Abstract available


  31. ZHAO X, Chen D, Szabla R, Zheng M, et al
    Broad and differential animal ACE2 receptor usage by SARS-CoV-2.
    J Virol. 2020 Jul 13. pii: JVI.00940-20. doi: 10.1128/JVI.00940.
    PubMed     Abstract available


  32. SMITH M, Honce R, Schultz-Cherry S
    Metabolic Syndrome and Viral Pathogenesis: Lessons from Influenza and Coronaviruses.
    J Virol. 2020 Jul 13. pii: JVI.00665-20. doi: 10.1128/JVI.00665.
    PubMed     Abstract available


  33. TABOADA B, Vazquez-Perez JA, Munoz Medina JE, Ramos Cervantes P, et al
    Genomic Analysis of Early SARS-CoV-2 Variants Introduced in Mexico.
    J Virol. 2020 Jul 8. pii: JVI.01056-20. doi: 10.1128/JVI.01056.
    PubMed     Abstract available


  34. ZHAO X, Zheng S, Chen D, Zheng M, et al
    LY6E Restricts the Entry of Human Coronaviruses, Including the Currently Pandemic SARS-CoV-2.
    J Virol. 2020 Jul 8. pii: JVI.00562-20. doi: 10.1128/JVI.00562.
    PubMed     Abstract available


  35. DERVAS E, Hepojoki J, Smura T, Prahauser B, et al
    Serpentoviruses, more than respiratory pathogens.
    J Virol. 2020 Jul 8. pii: JVI.00649-20. doi: 10.1128/JVI.00649.
    PubMed     Abstract available


  36. CHAKRAVARTY D, Saadi F, Kundu S, Bose A, et al
    CD4 Deficiency Causes Poliomyelitis and Axonal Blebbing in Murine Coronavirus-Induced Neuroinflammation.
    J Virol. 2020;94.
    PubMed     Abstract available


  37. DALMANN A, Reimann I, Wernike K, Beer M, et al
    Autonomously Replicating RNAs of Bungowannah Pestivirus: E(RNS) Is Not Essential for the Generation of Infectious Particles.
    J Virol. 2020;94.
    PubMed     Abstract available


  38. YIN L, Chen J, Li L, Guo S, et al
    Aminopeptidase N Expression, Not Interferon Responses, Determines the Intestinal Segmental Tropism of Porcine Deltacoronavirus.
    J Virol. 2020;94.
    PubMed     Abstract available


    June 2020
  39. MOORE JP, Klasse PJ
    SARS-CoV-2 vaccines: 'Warp Speed' needs mind melds not warped minds.
    J Virol. 2020 Jun 26. pii: JVI.01083-20. doi: 10.1128/JVI.01083.
    PubMed     Abstract available


  40. LIU Z, Zheng H, Lin H, Li M, et al
    Identification of common deletions in the spike protein of SARS-CoV-2.
    J Virol. 2020 Jun 22. pii: JVI.00790-20. doi: 10.1128/JVI.00790.
    PubMed     Abstract available


  41. DENG X, Buckley AC, Pillatzki A, Lager KM, et al
    Inactivating Three Interferon Antagonists Attenuates Pathogenesis of an Enteric Coronavirus.
    J Virol. 2020 Jun 17. pii: JVI.00565-20. doi: 10.1128/JVI.00565.
    PubMed     Abstract available


  42. DUTTA NK, Mazumdar K, Gordy JT
    The Nucleocapsid Protein of SARS-CoV-2: a Target for Vaccine Development.
    J Virol. 2020;94.
    PubMed    


  43. STRAUS MR, Tang T, Lai AL, Flegel A, et al
    Ca(2+) Ions Promote Fusion of Middle East Respiratory Syndrome Coronavirus with Host Cells and Increase Infectivity.
    J Virol. 2020;94.
    PubMed     Abstract available


  44. CHANG CY, Liu HM, Chang MF, Chang SC, et al
    Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Suppresses Type I and Type III Interferon Induction by Targeting RIG-I Signaling.
    J Virol. 2020;94.
    PubMed     Abstract available


    May 2020
  45. LU Y, Cai H, Lu M, Ma Y, et al
    Porcine epidemic diarrhea virus deficient in RNA cap guanine-N-7 methylation is attenuated and induces higher type I and III interferon responses.
    J Virol. 2020 May 27. pii: JVI.00447-20. doi: 10.1128/JVI.00447.
    PubMed     Abstract available


  46. ZHU X, Chen J, Tian L, Zhou Y, et al
    Porcine Deltacoronavirus nsp5 Cleaves DCP1A to Decrease Its Antiviral Ability.
    J Virol. 2020 May 27. pii: JVI.02162-19. doi: 10.1128/JVI.02162.
    PubMed     Abstract available


  47. MILEWSKA A, Kula-Pacurar A, Wadas J, Suder A, et al
    Replication of SARS-CoV-2 in human respiratory epithelium.
    J Virol. 2020 May 20. pii: JVI.00957-20. doi: 10.1128/JVI.00957.
    PubMed     Abstract available


  48. VOLK A, Hackbart M, Deng X, Cruz-Pulido Y, et al
    Coronavirus Endoribonuclease and Deubiquitinating Interferon Antagonists Differentially Modulate the Host Response during Replication in Macrophages.
    J Virol. 2020;94.
    PubMed     Abstract available


  49. DENG X, Chen Y, Mielech AM, Hackbart M, et al
    Structure-Guided Mutagenesis Alters Deubiquitinating Activity and Attenuates Pathogenesis of a Murine Coronavirus.
    J Virol. 2020;94.
    PubMed     Abstract available


  50. ZHAI X, Sun J, Yan Z, Zhang J, et al
    Comparison of SARS-CoV-2 spike protein binding to ACE2 receptors from human, pets, farm animals, and putative intermediate hosts.
    J Virol. 2020 May 13. pii: JVI.00831-20. doi: 10.1128/JVI.00831.
    PubMed     Abstract available


  51. ZHU Y, Yu D, Yan H, Chong H, et al
    Design of potent membrane fusion inhibitors against SARS-CoV-2, an emerging coronavirus with high fusogenic activity.
    J Virol. 2020 May 6. pii: JVI.00635-20. doi: 10.1128/JVI.00635.
    PubMed     Abstract available


  52. HOLLAND LA, Kaelin EA, Maqsood R, Estifanos B, et al
    An 81 nucleotide deletion in SARS-CoV-2 ORF7a identified from sentinel surveillance in Arizona (Jan-Mar 2020).
    J Virol. 2020 May 1. pii: JVI.00711-20. doi: 10.1128/JVI.00711.
    PubMed     Abstract available


    April 2020
  53. NGUYEN A, David JK, Maden SK, Wood MA, et al
    Human leukocyte antigen susceptibility map for SARS-CoV-2.
    J Virol. 2020 Apr 17. pii: JVI.00510-20. doi: 10.1128/JVI.00510.
    PubMed     Abstract available


  54. WANG M, Li M, Ren R, Li L, et al
    International expansion of a novel SARS-CoV-2 mutant.
    J Virol. 2020 Apr 8. pii: JVI.00567-20. doi: 10.1128/JVI.00567.
    PubMed     Abstract available


  55. LICASTRO D, Rajasekharan S, Dal Monego S, Segat L, et al
    Isolation and full-length genome characterization of SARS-CoV-2 from COVID-19 cases in Northern Italy.
    J Virol. 2020 Apr 1. pii: JVI.00543-20. doi: 10.1128/JVI.00543.
    PubMed     Abstract available


  56. CAGLIANI R, Forni D, Clerici M, Sironi M, et al
    Computational inference of selection underlying the evolution of the novel coronavirus, SARS-CoV-2.
    J Virol. 2020 Apr 1. pii: JVI.00411-20. doi: 10.1128/JVI.00411.
    PubMed     Abstract available


    January 2020
  57. WAN Y, Shang J, Graham R, Baric RS, et al
    Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS.
    J Virol. 2020 Jan 29. pii: JVI.00127-20. doi: 10.1128/JVI.00127.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO COVID-19 is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: